Hemostasis News and Research RSS Feed - Hemostasis News and Research

Hemostasis or haemostasis is a complex process which causes the bleeding process to stop. Most times this includes the changing of blood from a fluid to a solid state. Intact blood vessels are central to moderating blood's tendency to clot.
Qosina gets ISO-13485 certification for medical devices and components

Qosina gets ISO-13485 certification for medical devices and components

Qosina is pleased to announce that we have received ISO 13485 Certification, a globally recognized standard that specifies the requirements for a quality management system that can be used by organizations providing medical devices, components and delivery of related services. [More]
Richard Wolf to showcase new system solutions for minimally invasive human medicine at MEDICA 2016

Richard Wolf to showcase new system solutions for minimally invasive human medicine at MEDICA 2016

Richard Wolf GmbH is presenting its new system solutions for minimally invasive human medicine at the International Trade Fair for Medical Technology – MEDICA 2016, November 14-17, 2016 – at the newly designed exhibition booth under the motto “feel the spirit of excellence”. [More]
Boston Scientific launches novel technology to improve hemostatic clipping

Boston Scientific launches novel technology to improve hemostatic clipping

Boston Scientific Corporation today announced the launch of the Resolution 360 Clip, a novel technology designed to improve hemostatic clipping by providing physicians controlled rotation designed for more accurate clip placement. [More]
Study finds blood thinning drugs derived from cattle and pigs have equivalent anti-clotting properties

Study finds blood thinning drugs derived from cattle and pigs have equivalent anti-clotting properties

As demand for the widely used blood thinning drug heparin continues to grow, experts worry of possible shortages of the essential medication. [More]
Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer. [More]
Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Roughly one-third of all births in Europe and North America now occur via cesarean section (CS). Following any birth, women are at an increased risk for a venous thromboembolism (VTE), but it's believed that CS leaves women more vulnerable to VTE, blood clots, than vaginal delivery (VD). [More]
Qosina launches new barbed check valves for infusion, drainage and irrigation applications

Qosina launches new barbed check valves for infusion, drainage and irrigation applications

Qosina is pleased to announce the addition of eight new barbed check valves to complement their extensive line of stock components. Available in three different configurations, these barbed valves have a low, 0.087 psi cracking pressure. [More]
Novel antidote effective in quickly reversing acute anticoagulant-related bleeding

Novel antidote effective in quickly reversing acute anticoagulant-related bleeding

A specially designed antidote to reverse acute, potentially life-threatening anticoagulant-related bleeding worked quickly, and was well-tolerated according to interim results of the ongoing ANNEXA-4 study. [More]
New bioinspired device could diagnose formation of blood clots

New bioinspired device could diagnose formation of blood clots

When in dysfunction, the vascular endothelium -- the tissue that lines the blood vessels throughout our body's entire circulatory system -- plays a big role in the development of many human diseases, including diabetes, stroke, heart disease, viral infections and cancer. [More]
Siemens Healthineers launches fully-automated coagulation analyzer with PSI technology in the U.S.

Siemens Healthineers launches fully-automated coagulation analyzer with PSI technology in the U.S.

Today, Siemens Healthineers Laboratory Diagnostics business launched the Sysmex CS-2500 System—a mid-volume, fully-automated coagulation analyzer with smartly-designed PSI technology—in major markets including the U.S. Together with Lab Alliance of Central New York, the first U.S. customer to install the high-volume Sysmex CS-5100 System, the company celebrated the availability of its new Sysmex CS Hemostasis System portfolio in the U.S. [More]
VALIDATE D-Dimer kit from LGC Maine Standards receives US FDA approval for use on hemostasis test systems

VALIDATE D-Dimer kit from LGC Maine Standards receives US FDA approval for use on hemostasis test systems

LGC Maine Standards is pleased to announce our VALIDATE D-Dimer calibration verification / linearity test kit has received US FDA 510(k) clearance for use on Instrument Laboratory ACL TOP hemostasis test systems. [More]
Novel biomarkers may offer solution for detecting autologous blood transfusion in athletes

Novel biomarkers may offer solution for detecting autologous blood transfusion in athletes

Increasing oxygen delivery to muscles can help athletes perform better and give them the edge needed to win elite competitions. One of the best ways to increase oxygen supply is through blood manipulation, undergoing a blood transfusion that provides extra red blood cells and boosts oxygen levels. [More]

Essential Medical receives CE Mark approval for novel vascular closure device

Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device. [More]
UNC professor identifies research priorities to address VTE in cancer patients

UNC professor identifies research priorities to address VTE in cancer patients

More than 20 percent of all blood clots in veins occur in cancer patients. These clots, also known as venous thromboembolism (VTE), pose serious threats for cancer patients. [More]
Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses. [More]
Reasons for life-threatening blood clots in elite athletes

Reasons for life-threatening blood clots in elite athletes

Mary Cushman, M.D., M.Sc., a professor of medicine and director of the Thrombosis and Hemostasis Program at the University of Vermont, provides commentary on the causes of life-threatening blood clots in elite athletes. [More]
Researchers identify possible genetic basis for coronary artery disease

Researchers identify possible genetic basis for coronary artery disease

For many people, coronary artery disease, or CAD—the buildup of plaque in the heart's arteries—is an unfortunate part of aging. By studying the genetic makeup of those who manage to maintain clear arteries into old age, researchers have identified a possible genetic basis for the disease, as well as potential new opportunities to prevent it. [More]
New study sheds light on challenges in addressing post-operative bleeding in newborns

New study sheds light on challenges in addressing post-operative bleeding in newborns

A new study finds significant differences between the blood clot structure in adults and newborns, helping researchers better understand the challenges in addressing post-operative bleeding in neonatal patients. [More]
Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, announced today that it has submitted supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration seeking approval for the use of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] to treat children under the age of 12 with hemophilia A and for use in surgical settings. [More]
Wyss Institute scientists develop better assay for testing hemostasis

Wyss Institute scientists develop better assay for testing hemostasis

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function. [More]
Advertisement
Advertisement